Stocks analysis

AEE vs AIG Stock Comparison

Scores Breakdown

Metric AEE AIG
📈 Growth 0/30 23/30
💰 Profitability 12/20 12/20
🏦 Financial Health 14/20 15/20
💵 Valuation 12/20 10/20
⚠️ Risk (lower is better) 7/10 6/10
Overall Score 41/100 64/100

Side-by-Side Summaries

AEE Analysis AIG Analysis

📈 Growth & Financial Trajectory

Over eight quarters, Ameren's revenue progressed from $2.173B in 2024 Q2 to $2.176B in 2026 Q1, essentially flat. A standout spike occurred in 2025 Q3 at $2.699B, followed by a dip to $1.782B in 2025 Q4, then a return toward $2.2B. Net income moved unevenly, starting at $457M (Q2 2024) and ending at $358M (Q1 2026), with a peak of $640M in 2025 Q3.

💰 Margins & Cash Flow

Operating margins fluctuated, averaging around 24.6%, peaking at 39.3% (2025 Q1) and dipping to 10.2% (2024 Q4). Cash flow: net cash from operating activities was generally positive; investing activities were typically negative, and financing activity provided offsetting support in several quarters. The quarterly cadence yields solid operating cash flow in aggregate, aligning with a capital-intensive utility model.

🛡️ Balance Sheet & Liquidity

Total assets run near $49.8B with liabilities around $36.2B and equity of about $13.6B. Long-term debt sits near $19.4B, indicating a moderate debt load for a regulated utility. The balance sheet remains constructive, supported by recurring operating cash flows.

⚠️ Key Drivers & Risks

  • Drivers: Regulated utility framework and stable dividend policy; cash-flow visibility from rate cases.
  • Risks: Regulatory changes and weather-driven demand variability; interest-rate and valuation sensitivity.

📈 Growth & Financial Trajectory

Over the eight quarters, Revenues stayed broadly flat in the $6.4B–$7.2B range, peaking at about $7.18B in 2024 Q4 and easing to around $6.65B by 2026 Q1. Net income progressed from a sizable quarterly loss in 2024 Q3 (~-$3.88B) to positive earnings from 2024 Q4 onward, with a peak near $1.14B in 2025 Q2, then moderating to roughly $0.52B–$0.76B across 2025 Q3–2026 Q1. This reflects meaningful earnings leverage despite a relatively flat revenue base, with a notable mid-2025 uplift followed by stabilization.

💰 Margins & Cash Flow

Operating margins swung from the mid-teens to the low- to mid-20s in 2025 Q2 (peak around 22%), indicating strong operating leverage when volumes align with cost structure. Across quarters, the average margin sits in the low-teens, roughly around 12%. Operating cash flow was positive in most periods, signaling solid cash generation from core activities, while investing cash flow fluctuated and financing cash flow was typically negative, reflecting ongoing debt management and capital activity.

🛡️ Balance Sheet & Liquidity

Assets run roughly $160–$166B with liabilities near $120–$125B and equity around $40–$41B, suggesting a solid asset base and meaningful equity cushion. The structure implies resilience supported by recurring operating cash flow, albeit with ongoing financing activity.

⚠️ Key Drivers & Risks

  • Drivers: Steady core insurance volumes and favorable investment environment supporting earnings uplift.
  • Risks: Earnings volatility from reserve development and sensitivity to macro/regulatory shifts that can affect margins.